Delivery Order 36C24225D0064-36C24225N0477

Award Date 4/15/25
Potential Completion Date 4/14/26
Potential Value $636K
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, VA52815D0054|VA24216J0695, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract is for the delivery of radiopharmaceuticals to the Buffalo, NY VA medical facility from October 1, 2016 through September 30, 2017, with a total ceiling value of $126,360.00. This contract is a firm fixed-price delivery order, with no set-aside designation. Sofie CO. is a...
This is a federal contract award to Sofie CO., doing business as Sofie, a for-profit organization specializing in the development and delivery of molecular diagnostics and therapeutics. The $80,750 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) to provide PET (Positron Emission Tomography) pharmaceuticals. The contract is part of the VA's VISN 4 (Veterans Integrated Service Network 4) program and has an ultimate completion date of December 30, 2019. Sofie has...
This federal contract award to Sofie CO. is for the provision of nuclear medicine PET radioisotopes to the Department of Veterans Affairs (VA) Veterans Health Administration in Veterans Integrated Service Network 21. The $136,876.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics. The company has received numerous federal contract awards from the...
This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $171,500.00 firm fixed-price purchase order has an ultimate completion date of April 4, 2019 and was awarded on October 1, 2016. This contract is not set aside and is part of Sofie's broader portfolio of federal contracts and indefinite delivery vehicles (IDVs) to supply specialized radiopharmaceuticals, including PET imaging agents and...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., provides PET/CT radiopharmaceuticals to the Department of Veterans Affairs (VA). The $2,343,583.08 fixed-price contract was set aside for small businesses and is scheduled for completion by September 30, 2023. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with extensive experience in positron emission tomography (PET) imaging. The company has been a key provider of...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO. for the provision of pet radiopharmaceuticals. The contract has a potential value of $1,963,556.33 and is a firm fixed price contract with a completion date of September 30, 2022. There is no set-aside designation on this contract. Sofie CO. is a for-profit company that specializes in developing and delivering molecular diagnostics and therapeutics, including PET imaging...
This federal contract award, valued at $1,247,134.00, was issued by the Department of Veterans Affairs (VA) Network Contracting Office 21 to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of Positron Emission Tomography (PET) radiopharmaceuticals to the VA San Francisco Health Care System. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods, resulting in a potential...
This definitive contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO. (Sofie), a for-profit organization, for the delivery of PET radiopharmaceuticals. The $116,720.00 firm fixed price contract has an April 1, 2019 completion date and did not utilize a set-aside. Sofie is an experienced provider of molecular diagnostics and therapeutics to federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. The...
  • 36C24225D0064
    Indefinite Delivery Contract
  • 36C24225D0064-36C24225N0477
    Delivery Order

This federal contract award, with ID 36C24225D0064|36C24225N0477, was issued by the Veterans Integrated Service Network 2, a civilian agency under the Department of Veterans Affairs (VA). The contract, valued at $635,896.40, is a delivery order for the supply of pet radiopharmaceuticals to the Buffalo VA Medical Center. The contract was awarded to Sofie CO., a for-profit organization specializing in the development, production, and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals and positron emission tomography (PET) imaging agents. The contract has a firm fixed-price pricing type and an ultimate completion date of April 14, 2026. Sofie CO. is a subsidiary of Sofie Biosciences, Inc. and has been a key supplier of specialized medical imaging products and radiopharmaceuticals to federal healthcare agencies, including the VA and the Defense Health Agency (DHA), since its registration in 2001. The contract is not set aside, reflecting Sofie's established expertise in the field.

Generated 4/18/25, 2:01 PM